Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cengild Medical BhdXKLS:0243 -2.50%63 Equity-to-Asset is 0.53 as of Mar. 2026, which is 26% below its 10-year median of 0.72. GuruFocus rates XKLS:0243 with a GF Score™ of 63/100 and a GF Value™ of RM0.29 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 687 Healthcare Providers & Services companies, Cengild Medical Bhd ranks better than 55.46% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cengild Medical Bhd's Total Stockholders Equity for the quarter that ended in Mar. 2026 was RM115.87 Mil. Cengild Medical Bhd's Total Assets for the quarter that ended in Mar. 2026 was RM217.91 Mil.
Therefore, Cengild Medical Bhd's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.53.
The historical rank and industry rank for Cengild Medical Bhd's Equity-to-Asset or its related term are showing as below:
XKLS:0243'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.09 Med: 0.72 Max: 0.84
Current: 0.53
During the past 8 years, the highest Equity to Asset Ratio of Cengild Medical Bhd was 0.84. The lowest was 0.09. And the median was 0.72.
XKLS:0243's Equity-to-Asset is ranked better than 55.46% of 687
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs XKLS:0243: 0.53
Cengild Medical Bhd (XKLS:0243) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Cengild Medical Bhd Equity-to-Asset Related Terms
Cengild Medical Bhd Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Cengild Medical Bhd's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0243 vs HCA, THC, DVA: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Cengild Medical Bhd's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cengild Medical Bhd Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cengild Medical Bhd's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Cengild Medical Bhd's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Cengild Medical Bhd's Equity to Asset Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cengild Medical Bhd (XKLS:0243) has a Equity-to-Asset of 0.53 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Cengild Medical Bhd and its competitors. This is 26% below median its historical median of 0.72. Over the past decade, Cengild Medical Bhd's Equity-to-Asset has ranged from 0.09 to 0.84. According to the industry distribution chart, Cengild Medical Bhd ranks #306 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 44.5%.
Is Cengild Medical Bhd's Equity-to-Asset too high?
Cengild Medical Bhd's current Equity-to-Asset of 0.53 is 26% below median its 10-year median of 0.72. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 0.84. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Cengild Medical Bhd's value of 0.53 is 10.4% above this industry median. Based on the distribution chart, Cengild Medical Bhd ranks #306 out of 687 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Cengild Medical Bhd has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cengild Medical Bhd's Equity-to-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Cengild Medical Bhd ranks #306 out of 687 companies for Equity-to-Asset. This puts Cengild Medical Bhd in the upper half of its industry. The industry median Equity-to-Asset is 0.48. Cengild Medical Bhd's value of 0.53 is 10.4% above this benchmark. Historically, Cengild Medical Bhd's own Equity-to-Asset has ranged from 0.09 to 0.84 over the past decade. While the company's 10-year median is 0.72 vs. the industry median of 0.48, Cengild Medical Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cengild Medical Bhd's current Equity-to-Asset of 0.53 is 10.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Cengild Medical Bhd and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cengild Medical Bhd's current Equity-to-Asset is 0.53, which is 26% below median its own 10-year median of 0.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cengild Medical Bhd stock overvalued right now?
Based on GuruFocus' analysis, Cengild Medical Bhd (XKLS:0243) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.29, compared to a current price of RM0.20 — trading 32.8% below its estimated fair value. The current Equity-to-Asset is 0.53, which is 26% below median its 10-year median of 0.72 and 10.4% above the Healthcare Providers & Services industry median of 0.48. Cengild Medical Bhd's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Cengild Medical Bhd (XKLS:0243), the current Equity-to-Asset is 0.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cengild Medical Bhd (XKLS:0243) Overvalued in 2026?
Based on GuruFocus' analysis, Cengild Medical Bhd stock appears to be undervalued.
The current stock price of RM0.20 is trading 32.8% below its estimated GF Value™ of RM0.29.
GuruFocus considers Cengild Medical Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:0243:
Equity-to-Asset: 0.53 (26% below median its 10-year median of 0.72)
GF Value™: RM0.29 vs. price of RM0.20 (32.8% below fair value)
Industry Position: 10.4% above the Healthcare Providers & Services median (#306 of 687)
No single metric tells the full story. See the XKLS:0243 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
63GF Score
Get the complete analysis for XKLS:0243
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0243 has been successfully added to your 
